Our team is dedicated to impacting how central nervous system therapies are developed and delivered to patients.
We are passionate about engaging our clinical partners to solve problems with rigorous science.
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- Thank you #EAN2020 for the amazing #Virtual experience showing the great agility of the scientific world and the pa… https://t.co/rOOODzPH3S23 hours ago
- In #MS, tailoring treatment to the individual patient is key and can be done using prognostic factors such as… https://t.co/1tBQh4fzmg2 days ago
- Very interesting session at #EANVirtual #EAN2020 Combining core biomarkers including #MRI is key to improve differ… https://t.co/WYHj4XYMBr2 days ago
- RT @MSNewsToday: New Post: Sanofi’s BTK Inhibitor Seen to Effectively Reduce Brain Lesions in Phase 2 Trial https://t.co/oXmBafM8mr https:/…30 days ago
130, rue de Lourmel
75015 Paris – France